Does RASBURICASE Cause Drug ineffective? 71 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 71 reports of Drug ineffective have been filed in association with RASBURICASE (Elitek). This represents 8.0% of all adverse event reports for RASBURICASE.
71
Reports of Drug ineffective with RASBURICASE
8.0%
of all RASBURICASE reports
22
Deaths
39
Hospitalizations
How Dangerous Is Drug ineffective From RASBURICASE?
Of the 71 reports, 22 (31.0%) resulted in death, 39 (54.9%) required hospitalization, and 17 (23.9%) were considered life-threatening.
Is Drug ineffective Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RASBURICASE. However, 71 reports have been filed with the FAERS database.
What Other Side Effects Does RASBURICASE Cause?
Tumour lysis syndrome (116)
Methaemoglobinaemia (92)
Off label use (90)
Product use in unapproved indication (76)
Bacterial infection (75)
Fungal infection (73)
Cellulitis (72)
Clostridium difficile colitis (72)
Lymphoid tissue hypoplasia (72)
Lymphopenia (72)
What Other Drugs Cause Drug ineffective?
ADALIMUMAB (71,926)
METHOTREXATE (70,142)
ETANERCEPT (60,367)
ADAPALENE (52,181)
ABATACEPT (35,212)
INFLIXIMAB (33,738)
TOCILIZUMAB (32,342)
RITUXIMAB (32,186)
LEFLUNOMIDE (31,396)
HYDROXYCHLOROQUINE (31,057)
Which RASBURICASE Alternatives Have Lower Drug ineffective Risk?
RASBURICASE vs RAVULIZUMAB
RASBURICASE vs RAVULIZUMAB-CWVZ
RASBURICASE vs REBAMIPIDE
RASBURICASE vs REBETOL
RASBURICASE vs REBIF